Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
FDA de novo clearance
Viz.ai’s stroke-detecting CDS app receives FDA nod
By
Dave Muoio
|
05:07 pm |
February 14, 2018
Pear Therapeutics gets de novo FDA clearance for reSET, a digital therapeutic for substance abuse
By
Jonah Comstock
|
04:33 pm |
September 14, 2017
23andMe raises $79 million as it shifts focus to research, drug development
By
Jonah Comstock
|
10:34 am |
July 06, 2015
First page
« First
Previous page
‹‹
Page
1
Current page
2